menu
    • menu

    Company profile for Bioeq IP AG

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Bioeq IP AG is a Swiss biopharmaceutical joint venture between the leading Polish pharmaceutical group Polpharma and the Strüngmann family’s investment company. Bioeq licenses, develops and commercializes biological successor products of successful biopharmaceuticals, called biosimilars. FYB201 is currently the most advanced biosimilar program of Bioeq. The clinical studies and registration are conducted by a subsidiary, Bi...
    Bioeq IP AG is a Swiss biopharmaceutical joint venture between the leading Polish pharmaceutical group Polpharma and the Strüngmann family’s investment company. Bioeq licenses, develops and commercializes biological successor products of successful biopharmaceuticals, called biosimilars. FYB201 is currently the most advanced biosimilar program of Bioeq. The clinical studies and registration are conducted by a subsidiary, Bioeq GmbH based in Holzkirchen, Germany, on behalf of Bioeq IP AG.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bioeq IP AGSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Waldmannstrasse 8 8001 Zurich
    Telephone
    Telephone
    +41 44 533 41 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://bioeq.ch/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/bioeq-ip-ag
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    FDA Approves First Biosimilar to Lucentis
    FDA Approves First Biosimilar to Lucentis

    03 Aug 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-08-03/fda-approves-first-biosimilar-to-lucentis/?widget=listSection

    CONTRACTPHARMA
    03 Aug 2022
    Share Share
    Teva Receives Approval for First Ophthalmology Biosimilar in Europe
    Teva Receives Approval for First Ophthalmology Biosimilar in Europe

    20 May 2022

    // J. Nutovits LEXBLOG

    https://www.lexblog.com/2022/05/19/teva-receives-approval-for-first-ophthalmology-biosimilar-in-europe/

    J. Nutovits LEXBLOG
    20 May 2022
    Share Share
    FDA Accepts Review of Polpharma & Bioeq's BLA of Ranibizumab
    FDA Accepts Review of Polpharma & Bioeq's BLA of Ranibizumab

    04 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211004005408/en/Polpharma-Biologics-Group-Announces-that-the-Biologics-License-Application-BLA-Submitted-by-its-Joint-Venture-Bioeq-for-its-Biosimilar-Ranibizumab-has-Been-Accepted-for-Review-by-the-U.S.-Food-and-Drug-Administration-FDA

    BUSINESSWIRE
    04 Oct 2021
    Share Share
    Polpharma & Bioeq Joint Venture Submission of Biosimilar Ranibizumab BLA to FDA
    Polpharma & Bioeq Joint Venture Submission of Biosimilar Ranibizumab BLA to FDA

    06 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210806005315/it

    BUSINESSWIRE
    06 Aug 2021
    Share Share
    Bioeq has submitted a BLA to the FDA for the ranibizumab biosimilar
    Bioeq has submitted a BLA to the FDA for the ranibizumab biosimilar

    06 Aug 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210806005295/de

    BUSINESSWIRE
    06 Aug 2021
    Share Share
    Formycon & Bioeq announce submission of the BLA for FYB201
    Formycon & Bioeq announce submission of the BLA for FYB201

    05 Aug 2021

    // PRESS RELEASE

    https://www.formycon.com/en/press-release/formycon-and-bioeq-announce-submission-of-the-biologics-license-application-bla-for-fyb201-a-biosimilar-candidate-to-lucentisr1-ranibizumab-to-the-u-s-food-and-drug-administration-fda/

    PRESS RELEASE
    05 Aug 2021
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search